E-mail this page Printer Friendly Version RSS E-mail Alerts View contacts Download Financial Tear Sheet 

2014 Press Releases

This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.

Keyword Search
 
2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004
DateTitle 
12/09/14FDA Clears the Focus Diagnostics Simplexa™ Flu A/B & RSV Direct Test to Include Eight Circulating Influenza Viruses
CYPRESS, Calif. and MADISON, N.J., Dec. 9, 2014 /PRNewswire/ -- As the 2014-2015 flu season begins, Focus Diagnostics, the products business of Quest Diagnostics (NYSE: DGX), today announced that its Simplexa™ Flu A/B & RSV Direct Kit has received FDA clearance for eight additional influenza strains. These strains may pose significant potential health risks and may be circulating this winter. The FDA, which granted 510(k) clearance to the test kit originally in July 2012, cleared additional ... 
Printer Friendly Version
12/04/14Quest Diagnostics Declares Quarterly Cash Dividend
MADISON, N.J., Dec. 4, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.33 per share, payable on January 28, 2015 to shareholders of record of Quest Diagnostics common stock on January 13, 2015. About Quest Diagnostics Quest Diagnostics is the world's leading provider of diagnostic information services that patients and doctors need to ma... 
Printer Friendly Version
12/01/14Quest Diagnostics To Speak At The Piper Jaffray 26th Annual Healthcare Conference
MADISON, N.J., Dec. 1, 2014 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Piper Jaffray 26th Annual Healthcare Conference in New York City.  Mark Guinan, the company's Senior Vice President and CFO, will discuss the company's vision, goals and five point strategy.  The presentation is scheduled for Tuesday, December 2, 2014 at 9:30 a.m. Eastern Time. The presentation... 
Printer Friendly Version
11/05/14Quest Diagnostics Discusses Progress in Executing Strategy to Drive Shareholder Value and Presents Outlook at Investor Day
- Company Expects to Generate 2% to 5% Revenue Growth and Adjusted Diluted EPS Growth of 8% to 10% on Average Over Next Three Years - - New Target of $600 Million in Additional Run-Rate Savings Over Next Three Years Will Bring Total Run-Rate Savings Expected by End of 2017 to $1.3 billion - NEW YORK, Nov. 5, 2014 /PRNewswire/ -- At a meeting with analysts and investors at its Investor Day here today, members of the senior management team of Quest Diagnostics Incorporated (NYSE: DGX), the... 
Printer Friendly Version
11/04/14Quest Diagnostics Introduces BRCAvantage Plus™, Providing New Choices in Genetic Breast Cancer Risk Testing
First major service extension to the company's BRCAvantage™ BRCA1 and BRCA2 mutation test menu offers screening for five new non-BRCA genes shown to increase risk of inherited breast cancer MADISON, N.J., Nov. 4, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced BRCAvantage Plus, the company's first suite of lab-developed test services for assessing genetic breast cancer risk based on clinically validated non... 
Printer Friendly Version
10/23/14Quest Diagnostics Reports Third Quarter 2014 Financial Results
MADISON, N.J., Oct. 23, 2014 /PRNewswire/ -- Revenues from continuing operations of $1.9 billion, up 6.5% versus prior year Adjusted diluted EPS from continuing operations of $1.10, up 7.8% versus prior year Reported diluted EPS from continuing operations of $0.88, compared to $2.66 in 2013, which included a net gain of $1.80 per diluted share from asset sales Full year 2014 revenues now expected to grow approximately 3.5%, versus 2.5% to 3.5% previously Full year 2014 adjusted dilu... 
Printer Friendly Version
10/22/14Quest Diagnostics Adds Jeffrey M. Leiden, M.D., Ph.D., to Board of Directors
MADISON, N.J., Oct. 22, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors has elected Jeffrey M. Leiden, M.D., Ph.D., to serve as a director, effective December 1, 2014. Including Dr. Leiden, the Board has 11 members. Dr. Leiden is the Chairman, President and CEO of Vertex Pharmaceuticals.   Dr. Leiden has more than 20 years of scientific and commercial experience in the pharmaceut... 
Printer Friendly Version
10/07/14Quest Diagnostics To Release Third Quarter 2014 Financial Results On October 23
MADISON, N.J., Oct. 7, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report third quarter 2014 results on Thursday, October 23, 2014, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day. The conference call can also be accessed in listen-only mode by dialing 415-228-4961, passcode 3214469. The company suggests pa... 
Printer Friendly Version
10/02/14Quest Diagnostics Unveils New State-of-the-Art Clinical Laboratory in Marlborough, Massachusetts
Congresswoman Niki Tsongas, Representative Danielle Gregoire and Marlborough Mayor Arthur Vigeant join community event to open 200,000 square-foot "lab of the future" designed to deliver innovative, efficient diagnostic information services to New England Medical experts from UMass Memorial Medical Group and the University of Massachusetts to provide scientific leadership for testing onsite MARLBOROUGH, Mass., Oct. 2, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leadin... 
Printer Friendly Version
10/01/14Quest Diagnostics Names Mayo Clinic Executive Franklin R. Cockerill, M.D., Vice President and Chief Laboratory Officer
Former president and CEO of Mayo Medical Laboratories and chair of lab medicine and pathology for Mayo Clinic to oversee Quest's clinical testing operations MADISON, N.J., Oct. 1, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that Franklin R. Cockerill, III, M.D., has joined the company as vice president and chief laboratory officer, effective October 1, 2014. Dr. Cockerill w... 
Printer Friendly Version
10/01/14Quest Diagnostics To Host Investor Day On November 5, 2014
MADISON, N.J., Oct. 1, 2014 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the  world's leading provider of diagnostic testing, information and services, will host Investor Day for institutional investors and financial analysts in New York City on Wednesday, November 5, 2014 at The Hudson Theatre at the Millennium Broadway, 145 West 44th Street, New York, NY.  During the event, Quest Diagnostics executives will discuss the company's strategy, performance and plans to drive s... 
Printer Friendly Version
09/12/14Quest Diagnostics Marks 10 Years on the Dow Jones Sustainability Index
MADISON, N.J., Sept. 12, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today celebrates a decade on the North America Dow Jones Sustainability Index (DJSI) and 11 consecutive years on the World DJSI. The Dow Jones Sustainability Index family ranks companies for corporate sustainability according to economic, environmental and social criteria. To be included or remain in the index, companies must continually intensify th... 
Printer Friendly Version
09/11/14Workforce Drug Test Positivity Rate Increases for the First Time in 10 Years, Driven by Marijuana and Amphetamines, Finds Quest Diagnostics Drug Testing Index™ Analysis of Employment Drug Tests
Colorado and Washington experience surges in marijuana tests positivity rate, but data suggests state legalization of recreational marijuana may not be sole driver of increases MADISON, N.J., Sept. 11, 2014 /PRNewswire/ -- The percentage of positive drug tests among American workers has increased for the first time in more than a decade, fueled by a rise in marijuana and amphetamines, according to an analysis of 8.5 million urine, oral fluid and hair workplace drug test results released tod... 
Printer Friendly Version
09/08/14More People Testing Positive for Chikungunya Virus in the U.S., Finds Study at ICAAC 2014
Clinical testing volume and positivity rate both grew after the first case of the infectious disease spread to Western Hemisphere this year MADISON, N.J., Sept. 8, 2014 /PRNewswire/ -- A growing number of patients in the United States are being tested – and testing positive – for the mosquito-borne chikungunya virus, according to a study presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Washington, D.C. The study, by scientists from Quest Diagnosti... 
Printer Friendly Version
09/04/14Quest Diagnostics To Speak At The Morgan Stanley Global Healthcare Conference
MADISON, N.J., Sept. 4, 2014 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Morgan Stanley Global Healthcare Conference in New York City. Steve Rusckowski, the company's President and CEO, will discuss the company's vision, goals and five point strategy.  The presentation is scheduled for Monday, September 8, 2014 at 10:30 a.m. Eastern Time. The presentation will be w... 
Printer Friendly Version
08/27/14Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study
Testing for the protein 14-3-3eta may improve the diagnosis of RA, including in early stages when treatment is most likely to improve outcomes MADISON, N.J., Aug. 27, 2014 /PRNewswire/ -- A novel biomarker for rheumatoid arthritis (RA) has significant potential to help physicians better identify early-stage disease, when treatment can often arrest further disease progression and disability, according to a new study in The Journal of Rheumatology. Researchers from Quest Diagnostics (NYS... 
Printer Friendly Version
08/15/14Quest Diagnostics Declares Quarterly Cash Dividend
MADISON, N.J., Aug. 15, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.33 per share, payable on October 22, 2014 to shareholders of record of Quest Diagnostics common stock on October 7, 2014. About Quest Diagnostics Quest Diagnostics is the world's leading provider of diagnostic information services needed to make better healthcare de... 
Printer Friendly Version
07/24/14Quest Diagnostics Reports Second Quarter 2014 Financial Results
MADISON, N.J., July 24, 2014 /PRNewswire/ -- Revenues from continuing operations of $1.9 billion, up 4.8% versus prior year Adjusted diluted EPS from continuing operations of $1.08, up 1.9% versus  prior year Reported diluted EPS from continuing operations of $0.92, 7% below prior year Cash from operations of $280 million, up 34% versus prior year Full year 2014 revenues now expected to be up 2.5% to 3.5%, versus up 2% to 4% previously Full year 2014 adjusted diluted EPS range na... 
Printer Friendly Version
07/23/14Quest Diagnostics Adds Vicky Gregg to Board of Directors
MADISON, N.J., July 23, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors has elected Vicky Gregg to serve as a director, effective immediately, expanding the Board to 10 members. Ms. Gregg served as the Chief Executive Officer of Chattanooga-based Blue Cross Blue Shield of Tennessee from 2003 through December 2012. Prior to being elected CEO, she served in a number of other leaders... 
Printer Friendly Version
07/16/14Decline in Prescription Drug Misuse More than Twice as High in States with Broad Drug Abuse Prevention Programs, New Quest Diagnostics Health Trends Study Finds
Three-year analysis of more than 1.4 million test results also shows majority of Americans continue to put health at risk through dangerous drug combinations and skipping doses MADISON, N.J., July 16, 2014 /PRNewswire/ -- Five states that have implemented multi-faceted prescription drug abuse prevention programs in recent years showed the highest rate of decline in prescription drug misuse rates nationwide, according to a new study issued today by Quest Diagnostics (NYSE: DGX), the world's ... 
Printer Friendly Version
07/07/14Quest Diagnostics To Release Second Quarter 2014 Financial Results On July 24
MADISON, N.J., July 7, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report second quarter 2014 results on Thursday, July 24, 2014, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day. The conference call can also be accessed in listen-only mode by dialing 415-228-4961, passcode 3214469. The company suggests part... 
Printer Friendly Version
06/10/14Quest Diagnostics Introduces bioMerieux THxID®-BRAF Companion Diagnostic to Advance Precision Medicine for Melanoma
MADISON, N.J., June 10, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today introduced a new cancer test service based on the FDA-approved THxID®-BRAF test from bioMerieux, a world leader in the field of in vitro diagnostics. The THxID®-BRAF test is a companion diagnostic for two treatments for melanoma. The test is intended to be used as an aid in selecting patients with melanoma whose tumors carry the BRAF V600E mutation fo... 
Printer Friendly Version
06/04/14Quest Diagnostics To Speak At The Goldman Sachs 35th Annual Global Healthcare Conference
MADISON, N.J., June 4, 2014 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Goldman Sachs 35th Annual Global Healthcare Conference in Rancho Palos Verdes, California. Mark Guinan, the company's Senior Vice President and Chief Financial Officer and Jay Wohlgemuth, M.D., Senior Vice President, Medical, Science and Innovation, will discuss the company's vision, goals and five-... 
Printer Friendly Version
06/01/14Memorial Sloan Kettering Cancer Center and Quest Diagnostics Partner to Advance Precision Medicine in Cancer Diagnosis and Treatment
Diagnostic insights into gene mutations in solid tumor cancers will aid therapy selection and prognosis for patients and advance research NEW YORK and MADISON, N.J., June 1, 2014 /PRNewswire/ -- Memorial Sloan Kettering Cancer Center, the world's oldest and largest private cancer center, and Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced a joint collaboration that will utilize MSK's clinical and research insights i... 
Printer Friendly Version
05/21/14Quest Diagnostics Declares Quarterly Cash Dividend
MADISON, N.J., May 21, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.33 per share, payable on July 23, 2014 to shareholders of record of Quest Diagnostics common stock on July 9, 2014. About Quest Diagnostics Quest Diagnostics is the world's leading provider of diagnostic information services that patients and doctors need to make bett... 
Printer Friendly Version
05/05/14Quest Diagnostics To Speak At The Deutsche Bank 39th Annual Health Care Conference
MADISON, N.J., May 5, 2014 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Deutsche Bank 39th Annual Heath Care Conference in Boston.  Stephen Rusckowski, the company's President and CEO, will discuss the company's vision, goals and five-point strategy.  The presentation is scheduled for Thursday, May 8, 2014 at 10:00 a.m. Eastern Time. The presentation will be webcast... 
Printer Friendly Version
04/28/14Athena Diagnostics to Present Original Research on Neurogenetics at American Academy of Neurology's 2014 Annual Meeting
Company scientists advance understanding of role of genetics in seizure disorders, Charcot-Marie-Tooth disease and other conditions at top neurology industry conference MADISON, N.J., April 28, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that several scientists from its Athena Diagnostics specialty neurology business will present research during ... 
Printer Friendly Version
04/24/14Quest Diagnostics Reports First Quarter 2014 Financial Results
MADISON, N.J., April 24, 2014 /PRNewswire/ -- Full year revenue and adjusted earnings per diluted share guidance unchanged First quarter adjusted diluted EPS from continuing operations of $0.84, vs. $0.89 in 2013 First quarter adjusted diluted EPS was reduced by approximately $0.11 due to unseasonably harsh winter First quarter reported diluted EPS from continuing operations of $0.71, vs. $0.72 in 2013 First quarter revenues $1.75 billion, 2.3% below prior year Quest Diagnosti... 
Printer Friendly Version
04/23/14Quest Diagnostics Extends Partnership with Steward Health Care System
MADISON, N.J. and BOSTON, April 23, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Steward Health Care System LLC (Steward), New England's largest community-based accountable care organization and one of the nation's largest Pioneer ACOs, today announced that Quest has acquired the remainder of Steward's outreach laboratory service operations. Under the arrangement, Quest will provide outreach laboratory testing services t... 
Printer Friendly Version
04/23/14Next-Generation Gene Sequencing from Athena Diagnostics Streamlines Epilepsy Diagnosis
Quest Diagnostics' specialty neurology business unveils 10 new epilepsy diagnostic services, including industry's first clinical multi-analyte test for autoimmune epilepsy Test services to be unveiled at the AAN Annual Meeting, April 26 - May 4 in Philadelphia MADISON, N.J., April 23, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced a suite of new testing services from its Athena Diagnostics specialty neu... 
Printer Friendly Version
04/21/14Quest Diagnostics Completes Acquisition of Summit Health
MADISON, N.J., April 21, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, has completed the previously announced acquisition of Summit Health,  a leading provider of on-site prevention and wellness services. Financial terms were not disclosed. Health and wellness is a large and fast growing segment within the healthcare industry. A report by RAND Corp based on 2012 data found that 85% of employers with over 1,000 employees... 
Printer Friendly Version
04/07/14Patients Nationwide Now Have Direct Access to Lab Test Results through Quest Diagnostics
Company launches new website to enable patients to access lab data under federal rule that takes effect today Physicians who use Quest's Care360 EHR may qualify for Meaningful Use incentives MADISON, N.J., April 7, 2014 /PRNewswire/ -- For the first time, Americans nationwide can directly access their personal laboratory data through Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services. Quest Diagnostics provides diagnostic information services t... 
Printer Friendly Version
04/03/14Quest Diagnostics To Release First Quarter 2014 Financial Results On April 24
MADISON, N.J., April 3, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report first quarter 2014 results on Thursday, April 24, 2014, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day. The conference call can also be accessed in listen-only mode by dialing 415-228-4961, passcode 3214469. The company suggests par... 
Printer Friendly Version
03/24/14Focus Diagnostics Receives FDA Clearance for Moderate Complexity Simplexa® HSV 1 & 2 Direct Molecular Test for Aiding the Diagnosis of Encephalitis
Quest Diagnostics business launches first HSV PCR for CSF in United States. Test provides results in about 60 minutes. MADISON, N.J. and CYPRESS, Calif., March 24, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information and services, today announced that its Focus Diagnostics products business has received expedited FDA 510(k) clearance and CLIA moderate complexity categorization for its new Simplexa HSV 1 & 2 Direct molecular test on t... 
Printer Friendly Version
03/12/14Quest Diagnostics Incorporated Announces Proposed Senior Notes Offering
MADISON, N.J., March 12, 2014 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it intends to offer $600,000,000 in aggregate principal amount of two series of senior notes in a public offering made under a shelf registration statement filed with the Securities and Exchange Commission, subject to market and other conditions. The issuance of the notes will be subject to customary closing conditio... 
Printer Friendly Version
03/11/14Quest Diagnostics to Acquire Summit Health
Combined Offering to Accelerate Growth from Prevention and Wellness Programs MADISON, N.J., March 11, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has entered into a definitive purchase agreement under which Quest will acquire Summit Health. Terms of the transaction were not disclosed. Summit Health is a leading provider of on-site prevention and wellness programs primarily for employers. Fo... 
Printer Friendly Version
03/10/14Quest Diagnostics Completes Acquisition of Solstas Lab Partners and Raises 2014 Financial Guidance
- Full Year 2014 Revenues expected to grow 2% - 4% compared to 2013 - Full Year Adjusted Earnings Per Diluted Share to be between $3.95 and $4.15 MADISON, N.J., March 10, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it has completed the previously announced acquisition of Solstas Lab Partners Group and its subsidiaries (Solstas), a full-service commercial laboratory company based in Greensboro, N... 
Printer Friendly Version
02/26/14Quest Diagnostics Expands Hereditary Cancer Screening Offering with Lynch Syndrome Blood and Biopsy Testing for Colorectal Cancer
Company Supports March's Colorectal Cancer Awareness Month by Participating in the One Million Strong Screening Event in New York City on March 3 MADISON, N.J., Feb. 26, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced new pathology and blood test offerings to help identify and assess an individual's risk of Lynch syndrome, also known as hereditary nonpolyposis colorectal cancer (HNPCC), an inherited genetic... 
Printer Friendly Version
02/24/14Quest Diagnostics to Present Interoperability Solutions for Health Systems at HIMSS 2014
Retired New York Giants Player Stephen Baker to Join Quest as it Provides 100 Complimentary Blueprint for Wellness® Profiles at Booth 3064 on February 25 MADISON, N.J., Feb. 24, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, will exhibit at booth 3064 and host a series of "Tech Talks" and other programs during the HIMSS 2014 Annual Conference & Exhibition, the industry's largest health IT educational program and exhib... 
Printer Friendly Version
02/17/14Quest Diagnostics Announces Senior Leadership Appointments
-- John B. Haydon transitions to Vice President, Joint Ventures and Strategic Programs -- James E. Davis named Senior Vice President, Operations -- Lidia L. Fonseca named Senior Vice President and Chief Information Officer MADISON, N.J., Feb. 17, 2014 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced a series of senior leadership appointments designed to strengthen the management team as it executes t... 
Printer Friendly Version
02/14/14Quest Diagnostics To Speak At The 2014 RBC Capital Markets Global Healthcare Conference
MADISON, N.J., Feb. 14, 2014 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the RBC Capital Markets 2014 Global Healthcare Conference in New York.  Mark Guinan, the company's Senior Vice President and Chief Financial Officer, will discuss the company's vision, goals and five-point strategy.  The presentation is scheduled for Tuesday, February 25, 2014 at 8:30 a.m. Eastern Time... 
Printer Friendly Version
02/12/14ChartMaxx® from Quest Diagnostics Achieves Meaningful Use 2014 Certification from ICSA Labs
Enabling Health Systems to Qualify for CMS Financial Incentives MADISON, N.J. and CINCINNATI, Feb. 12, 2014 /PRNewswire/ -- ChartMaxx, the enterprise content management (ECM) solution from Quest Diagnostics (NYSE:DGX), has achieved 2014 Edition Modular EHR* ONC Health IT Certification which supports both Stages 1 and 2 of the Meaningful Use (MU) program. With the certification, health system providers who use the product may qualify for government financial incentives awarded to physicians ... 
Printer Friendly Version
02/05/14ChartMaxx® from Quest Diagnostics Earns 2013 'Best in KLAS' for Healthcare Document Management and Imaging Software Products
ChartMaxx Enterprise Content Management System Honored with Top Ranking for the Ninth Time MADISON, N.J., Feb. 5, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that its ChartMaxx® enterprise content management technology (ECM) solution was ranked the top healthcare Document Management and Imaging (DMI) software product, according to the 2013 Best in KLAS: Software & Services report, an independent ran... 
Printer Friendly Version
02/04/14Suboptimal Anticoagulant Treatment to Prevent Stroke Prevalent in Patients with Atrial Fibrillation, Finds Study in Circulation
The Quest Diagnostics Health Trends™ study of 2.7 million test results is the largest to examine warfarin treatment in patients with atrial fibrillation (Afib) treated in primary care and other non-hospital care settings in the United States Findings raise prospect that new oral anticoagulants may be more appropriate for some patients MADISON, N.J., Feb. 4, 2014 /PRNewswire/ -- Approximately one in two patients with atrial fibrillation (Afib) do not optimally reduce their risk of stroke ... 
Printer Friendly Version
02/03/14New Rules Opening Access to Lab Test Results Will Empower Patients to Take Control of Their Health
MADISON, N.J., Feb. 3, 2014 /PRNewswire/ -- A final rule issued today by the U.S. Department of Health and Human Services (HHS) giving Americans increased access to their personal health information will empower patients to exercise greater control over their health, according to Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services. (Logo: http://photos.prnewswire.com/prnh/20130717/NY48934LOGO ) "Patient engagement is essential to creating a health... 
Printer Friendly Version
01/30/14Quest Diagnostics Reports Fourth Quarter 2013 Financial Results; Provides Guidance For Full-Year 2014; Increases Dividend 10%
MADISON, N.J., Jan 30, 2014 /PRNewswire/ -- Fourth quarter adjusted diluted EPS from continuing operations of $1.03, 2% above prior year Fourth quarter reported diluted EPS from continuing operations of $0.97, 12% above prior year Fourth quarter revenues $1.76 billion, 1% below the prior year Full year 2014 revenues expected to be flat to 2% below the prior year, excluding Solstas acquisition Full year 2014 adjusted diluted EPS from continuing operations expected to be between $3.90... 
Printer Friendly Version
01/22/14Quest Diagnostics to Acquire Solstas Lab Partners
Transaction to give patients and healthcare providers in the Southeastern United States greater access to innovative and cost-effective diagnostic information services MADISON, N.J., Jan. 22, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has entered into a definitive agreement under which Quest will acquire Solstas Lab Partners Group and its subsidiaries (Solstas) for a total transaction value of ... 
Printer Friendly Version
01/17/14Quest Diagnostics To Release Fourth Quarter And Full Year 2013 Financial Results On January 30
MADISON, N.J., Jan. 17, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report fourth quarter and full year 2013 results on Thursday, January 30, 2014, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day. (Logo: http://photos.prnewswire.com/prnh/20130717/NY48934LOGO ) The conference call can also be accessed in li... 
Printer Friendly Version
01/13/14Quest Diagnostics Adds Timothy L. Main to Board of Directors
MADISON, N.J., Jan. 13, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors has elected Timothy L. Main to serve as a director, effective immediately. Including Mr. Main, the Board has 10 members. (Photo: http://photos.prnewswire.com/prnh/20140113/NY45552 ) (Logo: http://photos.prnewswire.com/prnh/20130717/NY48934LOGO ) Tim Main currently serves as Chairman of the Board of Director... 
Printer Friendly Version
01/09/14UC San Francisco and Quest Diagnostics Launch Collaboration to Advance the Field of Precision Medicine
MADISON, N.J. and SAN FRANCISCO, Jan. 9, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and the University of California, San Francisco (UCSF), the nation's leading university focused exclusively on health, have formed a collaboration to accelerate the translation of biomedical research into advanced diagnostics in the field of precision medicine, for improved patient care, treatment and outcomes. Initial clinical areas of foc... 
Printer Friendly Version